Our recent study highlighted intratumoral B cells as being prognostic based on both immunohistochemistry (IHC) for CD20 (protein), and by gene expression analysis of the corresponding gene, MS4A1 [19]. In contrast, CD20 expression in the peritumoral capsule, not the tumor itself, was suggested...